July 14, 2021
So Far, Not So Good: Neurologists Slow to Warm Up to Biogen’s Alzheimer Drug Aduhelm, Study Finds
From: FiercePharma
By: Beth Snyder Bulik
While almost 90% of neurologists are moderately or highly aware of Aduhelm, only 3% have written prescriptions so far, according to Spherix Global Insights latest data…(read more)